Molecular characterization of hepatitis B virus genotype D and recombinant strains among inmates and blood donors in Northeastern Kenya
Preprint
Abstract
Introduction: Hepatitis B virus (HBV) persists as a major global public health burden, with hyperendemic prevalence in sub-Saharan Africa. Populations with elevated exposure to percutaneous transmission risks—including incarcerated individuals and healthcare workers—demonstrate heightened HBV susceptibility. Despite this, genomic data from Northeastern Kenya and Kenyan prison populations remain scarce. Objective: To characterize HBV genotypic diversity circulating in Northeastern Kenya, among low risk (blood donors) and high-risk (prison inmates) populations. Methods: A cross-sectional investigation compared HBV seroprevalence and genotypes between incarcerated individuals (n = 130) and voluntary blood donors (n = 130) in Garissa County, Northeastern Kenya. Sample size was calculated using Casagrande’s formula for binomial comparison powered at 80% (α=0.05) to detect a ≥2-fold seroprevalence difference between cohorts. Serum samples underwent Hepatitis B surface antigen (HBsAg) screening, PCR amplification of a 940-bp overlapping surface/polymerase gene, sequencing, and phylogenetic/recombination analyses of the resulting sequences. Results: Seroprevalence was higher among incarcerated individuals (5.4%, 7/130) than blood donors (3.1%, 4/130). HBV DNA was detected in 22 samples. Genotype D dominated both cohorts (81.8%), while genotype A subgenotype A1 occurred exclusively in incarcerated participants (18.2%). All genotype D strains were recombinants: D/A (61%) and D/E (39%). Sequences are accessible in GenBank (accession numbers: PV816552 – PV816573 ). Conclusions: This first genomic study of HBV in Kenyan prisons confirms incarcerated populations as high-risk. The predominance of genotype D—a novel finding in this region—and high recombinant frequency (100% of genotype D strains) underscore significant viral evolution. Expanded genomic surveillance is imperative to define HBV diversity, inform vaccine efficacy monitoring, and optimize control strategies in Northeastern Kenya.Keywords
This publication has 27 references indexed in Scilit:
- A review of epidemiology and clinical relevance of Hepatitis B virus genotypes and subgenotypesClinics and Research in Hepatology and Gastroenterology, 2023
- Mapping hepatitis B virus genotypes on the African continent from 1997 to 2021: a systematic review with meta-analysisScientific Reports, 2023
- Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review articleInfection, Genetics and Evolution, 2022
- A novel hepatitis B virus recombinant genotype D4/E identified in a South African populationHeliyon, 2019
- Hepatitis B virus genotypes and unique recombinants circulating among outpatients in selected hospitals in KenyaInternational Journal of Infectious Diseases, 2016
- Hepatitis B virus intergenotypic recombinants worldwide: An overviewInfection, Genetics and Evolution, 2015
- Hepatitis B virus subgenotype A1, occurrence of subgenotype D4, and S gene mutations among voluntary blood donors in KenyaVirus Genes, 2013
- Genotyping and molecular characterization of hepatitis B virus in liver disease patients in KenyaInfection, Genetics and Evolution, 2013
- Molecular characterization of hepatitis B virus and a 9‐year clinical profile in a patient infected with genotype IJournal of Medical Virology, 2010
- A fluorimetric method for the estimation of G + C mol% content in microorganisms by thermal denaturation temperatureEnvironmental Microbiology, 2002